Abbonarsi

Short-term PM2.5 exposure and early-readmission risk: a retrospective cohort study in North Carolina heart failure patients - 28/04/22

Doi : 10.1016/j.ahj.2022.02.015 
Lauren H. Wyatt, MS, PhD a, Anne M. Weaver, MS, PhD a, Joshua Moyer, BS a, Joel D. Schwartz, PhD b, Qian Di, MS, PhD c, David Diaz-Sanchez, PhD a, Wayne E. Cascio, MD a, Cavin K. Ward-Caviness, PhD a,
a Center for Public Health and Environmental Assessment, United States Environmental Protection Agency, Research Triangle Park, NC 
b T.H. Chan School of Public Health, Harvard University, Boston, MA 
c Vanke School of Public Health, Tsinghua University, Beijing, China 

Reprint requests: Cavin Ward-Caviness, PhD, United States Environmental Protection Agency, Research Triangle Park, NC, 27514.United States Environmental Protection AgencyResearch Triangle ParkNC27514

Riassunto

Background

Short-term changes in ambient fine particulate matter (PM2.5) increase the risk for unplanned hospital readmissions. However, this association has not been fully evaluated for high-risk patients or examined to determine if the readmission risk differs based on time since discharge. Here we investigate the relation between ambient PM2.5 and 30-day readmission risk in heart failure (HF) patients using daily time windows and examine how this risk varies with respect to time following discharge.

Methods

We performed a retrospective cohort study of 17,674 patients with a recorded HF diagnosis between 2004 and 2016. The cohort was identified using the EPA CARES electronic health record resource. The association between ambient daily PM2.5 (μg/m3) concentration and 30-day readmissions was evaluated using time-dependent Cox proportional hazard models. PM2.5 associated readmission risk was examined throughout the 30-day readmission period and for early readmissions (1-3 days post-discharge). Models for 30-day readmissions included a parametric continuous function to estimate the daily PM2.5 associated readmission hazard. Fine-resolution ambient PM2.5 data were assigned to patient residential address and hazard ratios are expressed per 10 μg/m3 of PM2.5. Secondary analyses examined potential effect modification based on the time after a HF diagnosis, urbanicity, medication prescription, comorbidities, and type of HF.

Results

The hazard of a PM2.5-related readmission within 3 days of discharge was 1.33 (95% CI 1.18-1.51). This PM2.5 readmission hazard was slightly elevated in patients residing in non-urban areas (1.43, 95%CI 1.22-1.67) and for HF patients without a beta-blocker prescription prior to the readmission (1.35; 95% CI 1.19-1.53).

Conclusion

Our findings add to the evidence indicating substantial air quality-related health risks in individuals with underlying cardiovascular disease. Hospital readmissions are key metrics for patients and providers alike. As a potentially modifiable risk factor, air pollution-related interventions may be enacted that might assist in reducing costly and burdensome unplanned readmissions.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract




Image, graphical abstract

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2022  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 248

P. 130-138 - Giugno 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium
  • Muhammad Zubair Israr, Hong Zhan, Andrea Salzano, Adriaan A Voors, John G Cleland, Stefan D Anker, Marco Metra, Dirk J van Veldhuisen, Chim C Lang, Faiez Zannad, Nilesh J Samani, Leong L Ng, Toru Suzuki, BIOSTAT-CHF investigators (full author list as appendix)
| Articolo seguente Articolo seguente
  • Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices
  • William W. O'Neill, Mark Anderson, Daniel Burkhoff, Cindy L. Grines, Navin K. Kapur, Alexandra J. Lansky, Salvatore Mannino, James M. McCabe, Khaldoon Alaswad, Ramesh Daggubati, David Wohns, Perwaiz M. Meraj, Duane S. Pinto, Jeffrey J. Popma, Jeffrey W. Moses, Theodore L. Schreiber, E. Magnus Ohman

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.